Biotechnology firm Noxilizer, which manufactures sterilization technology for medical devices and equipment, has bought SAIAN Corp. in an assets acquisition, reports the Baltimore Business Journal.
According to a statement from the company, “Both companies have been involved in developing nitrogen dioxide as a sterilization solution for pharmaceutical, biotech and medical device companies, as well as hospitals.”
Read the Baltimore Business Journal story.
As Technically Baltimore reported in November, Noxilizer has been growing quickly, adding employees and receiving $500,000 from the Mount Vernon-based Abell Foundation. The company recently moved from the UMBC Research and Technology Park to the University of Maryland BioPark.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
These 10 regions could be most impacted by federal return-to-office mandates
From Belgaum to Baltimore and beyond, this founder leaned on family to build a biotech juggernaut
Tech-related orders and economic reorganizations hit Maryland. Here’s what they mean.
